This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Alamar Biosciences, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: The Innovations of Wei Feng
Introduction
Wei Feng is an accomplished inventor based in Union City, CA (US). He has made significant contributions to the field of immunoassays, holding a total of 3 patents. His work focuses on developing highly sensitive detection methods that have the potential to advance medical diagnostics.
Latest Patents
Wei Feng's latest patents include the Nucleic Acid Linked Immune-Sandwich Assay (NULISA). This innovative technology utilizes a capture/release mechanism to minimize non-specific binding, achieving detection with attomolar-level sensitivity. The patents also disclose kits designed for conducting these highly sensitive immunoassays, further enhancing their practical application in various settings.
Career Highlights
Wei Feng is currently employed at Alamar Biosciences, Inc., where he continues to push the boundaries of immunoassay technology. His expertise and innovative approach have positioned him as a key player in the field, contributing to advancements that could significantly impact healthcare.
Collaborations
Wei Feng collaborates with talented individuals such as Yuling Luo and Adrian Grzybowski. Their combined efforts foster a creative environment that drives innovation and enhances the development of new technologies.
Conclusion
Wei Feng's contributions to the field of immunoassays exemplify the impact of innovative thinking in medical diagnostics. His patents and ongoing work at Alamar Biosciences, Inc. highlight the importance of advancements in this critical area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile